Article info
PDFCochrane corner
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
- Correspondence to Dr Amand Floriaan Schmidt, Institute of Cardiovascular Science, University College London, London WC1E 6BT, UK; amand.schmidt{at}ucl.ac.uk
Citation
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
Publication history
- First published November 23, 2021.
Online issue publication
January 11, 2022
Article Versions
- Previous version (10 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.